Gates Package — page 258

Members of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Partnership Hanneke Schuitemaker, Ph.D. Global Head of Viral Vaccine Discovery and Translational Medicine, Johnson & Johnson; Professor, Virology, Amsterdam University Medical Center, University of Amsterdam Jonathan Seals, Ph.D. Director, Strategic Science and Technology Biomedical Advanced Research and Development Authority Jim Tartaglia, Ph.D. Vice President for Research and Development Sanofi Pasteur Tonya Villafana, M.P.H., Ph.D. Vice President, Global Franchise Head, Infection AstraZeneca Tal Zaks, M.D., Ph.D. Chief Medical Officer Moderna, Inc. FNIH Project Management Maria Freire, Ph.D. President and Executive Director FNIH Steve Paul, M.D. Chairman, FNIH; Chief Executive Officer and Chairman, Karuna Therapeutics David Wholley, M.Phil. Senior Vice President of Research Partnerships FNIH Joseph Menetski, Ph.D. Associate Vice President of Research Partnerships FNIH Stacey Adam, Ph.D. Director, Cancer, Research Partnerships FNIH Karen Tountas, Ph.D. Scientific Program Manager FNIH Michael Santos, Ph.D. Associate Vice President, Science FNIH